Abbott Laboratories - Exact Sciences
Abbott Laboratories (**Abbott**), via its wholly owned subsidiary Badger Merger Sub I, Inc, proposes to acquired 100% of the shares in Exact Sciences Corporation (**Exact Sciences**) through an Agreement and Plan of Merger. Abbott is a global healthcare company, headquartered in the US, active in the provision of diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. Exact Sciences is a US headquartered company active in the provision of advanced molecular diagnostics, specialising in cancer screening, precision oncology diagnostics, and genetic testing. The parties both supply oncological diagnostic products in Australia.
- Status
- Assessment completed
- ACCC determination
- Approved
- Stage
- Phase 1 - initial assessment
- Notified
- 2 February 2026
- Determination published
- 24 February 2026
Acquirers
- Badger Merger Sub I, Inc
Targets
- Exact Sciences Corporation